Synovitis Completed Phase 2 Trials for Methotrexate (DB00563)

IndicationStatusPhase
DBCOND0016437 (Synovitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00001677Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and EfficacyTreatment